- <1085.1> Use of Recombinant Reagents in the Bacterial Endotoxins Test: Comments Received from Stakeholders (posted 18–Nov–2020; updated 11–Dec–2020)
- Deferred Proposal: General Notices and Requirements, 5.60.40 Impurities that are Unusually Toxic and/or Mutagenic (posted 30–Sep–2020)
- First Draft of Roadmap for Addressing Element-Specific Chapters and Tests in Excipient Monographs (posted 05–Aug–2020)
- Modification to USP–NF 2021, Issue 2 Revisions, Deferrals, and Cancellations Lists (posted 29–Jan–2021)
- New Inhalation Product Monographs: Proposed Approach for Performance Tests using Non-standard Apparatus (posted 28–Aug–2020; comment deadline 30–Nov–2020)
- Revision Bulletin Notice Posting Update (posted 26–Mar–2021) | En español
- Update: Guidance on the Use of Recombinant Reagents for Bacterial Endotoxin Test (posted 28–Aug–2020)
- Update: Reporting Thresholds in USP–NF Monographs (posted 12–Oct–2020)
Publication Announcements
- Monographs Affected by Revision to <941> Characterization of Crystalline and Partially Crystalline Solids by X-Ray Powder Diffraction (XRPD) (posted 06–Apr–2021)
- Removal of Pop-up Text on Monographs for Selected Angiotensin II Receptor Blockers (ARB) (posted 26–Feb–2021)
- USP–NF Online: Upcoming Corrections to Official Dates in History Tab and Banner (posted 15–Jan–2021; updated 01–Mar–2021)
- Impact of Extended Implementation of USP–NF Platform Starting on November 1, 2020 until December 1, 2020 (posted 23–Oct–2020) | En español
- List of monographs appearing in redesigned format as of USP–NF 2021, Issue 1 (posted 25–Nov–2020)
- List of monographs appearing in redesigned format as of USP–NF 2021, Issue 2 (posted 02–Feb–2021)
- List of monographs appearing in redesigned format as of USP–NF 2021, Issue 3 (posted 01–Jun–2021)
- List of monographs appearing in redesigned format as of USP 43-NF 38 2S (posted 29–May–2020)
- Monographs Affected by Revision to <601> Inhalation and Nasal Drug Products: Aerosols, Sprays, and Powders—Performance Quality Tests (posted 02–Oct–2020)
- Monograph Affected by Revision to <1195> Significant Change Guide for Bulk Pharmaceutical Excipients (posted 02–Oct–2020)
- Monographs Affected by Revision to <1788> Methods for the Determination of Particulate Matter in Injections and Ophthalmic Solutions (posted 02–Oct–2020)
- PF Online: Changes in Official Publication Targets (posted 17–Jul–2020)